<?xml version="1.0" encoding="UTF-8"?>
<p>From April 2016 to November 2017, clinical samples were collected at the Urgency Medical Service Unity and State Hospital Dirceu Arcoverde in the city of Parnaiba, Piaui State, Brazil. Serum were obtained from whole blood samples collected from patients presenting two or more of the following symptoms: fever (&gt;38.5 °C), headache, arthralgia, myalgia, rash and/or hemorrhagic manifestations. Informed consent was obtained from all the patients or their legal guardians, and a form with questions about age, days of symptoms, travel history and previous diagnostics was filled out. The collected samples were stored at 4 °C, transported to the research laboratory at the Federal University of Piaui within 5 h after collection and stored at -70 °C. When available, results of the serological tests for DENV and CHIKV performed by public health services were retrieved. The research was approved by the Human and Ethics Committee of the Federal University of Piaui, under the protocol Nº CAAE 46111615.0.0000.5214.</p>
